Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.

Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.

<h4>Background/objective</h4>Despite multiple attempts, no surrogate biomarker of Parkinson disease (PD) has been definitively identified. Alternatively, identifying a non-invasive biomarker is crucial to understanding the natural history, severity, and progression of PD and to guide fut...

Full description

Bibliographic Details
Main Authors:	Fabrice Lucien, Eduardo E Benarroch, Aidan Mullan, Farwa Ali, Bradley F Boeve, Michelle M Mielke, Ronald C Petersen, Yohan Kim, Cole Stang, Emanuele Camerucci, Owen A Ross, Zbigniew K Wszolek, David Knopman, James Bower, Wolfgang Singer, Rodolfo Savica
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0264446

Similar Items

Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
by: Pierpaolo Turcano, et al.
Published: (2024-05-01)

Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
by: Laura N. Puentes, et al.
Published: (2021-06-01)

Protocol for the intracerebral injection of AAV-α-synuclein plus poly(ADP-ribose) to generate a Parkinson’s disease monkey model
by: Shuyi Liu, et al.
Published: (2025-03-01)

Methods for Purification of Proteins Associated with Cellular Poly(ADP-Ribose) and PARP-Specific Poly(ADP-Ribose)
by: Rood, Jennifer E., et al.
Published: (2014)

In Vivo Level of Poly(ADP-ribose)
by: Masanao Miwa, et al.
Published: (2018-05-01)

Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
by: Chandra Shaker Sriram, et al.
Published: (2015-01-01)

Molecular bases of catalysis and ADP-ribose preference of human Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase and conversion by mutagenesis to a preferential cyclic ADP-ribose phosphohydrolase.
by: Alicia Cabezas, et al.
Published: (2015-01-01)

The Antiviral Activities of Poly-ADP-Ribose Polymerases
by: Mathilde Malgras, et al.
Published: (2021-03-01)

ARH Family of ADP-Ribose-Acceptor Hydrolases
by: Hiroko Ishiwata-Endo, et al.
Published: (2022-11-01)

Adp-ribosyl cyclase and cyclic ADP-ribose hydrolase act as a redox sensor. a primary role for cyclic ADP-ribose in hypoxic pulmonary vasoconstriction.
by: Wilson, H, et al.
Published: (2001)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
by: Emad Matanes, et al.
Published: (2021-10-01)

Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases
by: Jie Tong, et al.
Published: (2022-11-01)

Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes.
by: Samuel Kasson, et al.
Published: (2021-01-01)

Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins
by: Kathrin Nowak, et al.
Published: (2020-10-01)

Risk of hospitalization in synucleinopathies and impact of psychosis
by: Capucine Piat, et al.
Published: (2023-09-01)

Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose.
by: Boittin, F, et al.
Published: (2003)

Synthesis and use of cell-permeant cyclic ADP-ribose.
by: Rosen, D, et al.
Published: (2012)

Cyclic ADP ribose as a calcium-mobilizing messenger.
by: Galione, A, et al.
Published: (2000)

Pharmacological characterization of the putative cADP-ribose receptor.
by: Thomas, J, et al.
Published: (2001)

Changes in NAD/ADP-ribose metabolism in rectal cancer
by: L. Yalcintepe, et al.
Published: (2005-03-01)

Poly(ADP-ribose) Polymerase-1 in the Nervous System
by: Hyo Chol Ha, et al.
Published: (2000-08-01)

Molecular Insights into Poly(ADP-ribose) Recognition and Processing
by: Ivan Ahel, et al.
Published: (2012-12-01)

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01)

Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
by: Markus Dahl, et al.
Published: (2014-01-01)

Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
by: Xiaoxue Xu, et al.
Published: (2023-10-01)

Poly ADP-ribose polymerase-1: an international molecule of mystery.
by: Woodhouse, B, et al.
Published: (2008)

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
by: Slade, D, et al.
Published: (2011)

Family-wide analysis of poly(ADP-ribose) polymerase activity
by: Vyas, Sejal, et al.
Published: (2015)

Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase.
by: Dunstan, MS, et al.
Published: (2012)

Neuronal accumulation of poly(ADP-ribose) after brain ischaemia.
by: Love, S, et al.
Published: (1999)

The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis
by: Samuel García, et al.
Published: (2015-01-01)

The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Gliomas
by: Nazanin Majd, et al.
Published: (2020-11-01)

Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.
by: David M Burns, et al.
Published: (2009-01-01)

Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
by: Maurie Markman
Published: (2018-01-01)

Crystallographic and biochemical analysis of the mouse poly(ADP-ribose) glycohydrolase.
by: Zhizhi Wang, et al.
Published: (2014-01-01)

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
by: M. Javle, et al.
Published: (2011-11-01)

The Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase
by: Felix R. Althaus, et al.
Published: (2011-02-01)

Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization
by: Karin H. Müller, et al.
Published: (2019-06-01)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020-03-01)

Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
by: Chia-Hao Liu, et al.
Published: (2017-10-01)